Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant content changes were detected in the Study Details page; only minor visual/layout differences are visible between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:32:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T06:59:21.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T03:39:10.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 and the 'Back to Top' element was removed; overall core content remains unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T21:36:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:44:13.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has added significant information regarding drug therapies and resources related to thyroid cancer, while also removing some previously listed locations and specific drug information.
    Difference
    6%
    Check dated 2025-08-31T12:13:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.